A Retrospective Review of Rib Fracture Pain Management at a London Major Trauma Centre
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04863807 |
Recruitment Status :
Completed
First Posted : April 28, 2021
Last Update Posted : April 28, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Rib Fractures Pain, Acute | Procedure: Regional Anaesthesia |
Primary Objective The primary objective is to examine whether novel fascial plane blocks, e.g. SAPB and ESPB, are effective pain relief modalities in patients with rib fractures - the proportion of patients with a reduction in pain.
Secondary Objectives
The investigators review the safety profile and complications of TEA and alternative analgesic techniques such as ESPB and SAPB used for rib fracture management in our trauma centre. In particular the effects of regional anaesthesia techniques on:
- Opioid use
- Nausea & vomiting
- Respiratory complications
- Intubation & non-invasive ventilation (NIV)
- ICU admission for respiratory complications
The investigators will assess the duration of use and complication profile of regional anaesthetic techniques, including infection, analgesic failure and damage to other structures during insertion e.g. the lung.
Study Type : | Observational |
Actual Enrollment : | 1500 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | A Retrospective Review of Rib Fracture Pain Management at a London Major Trauma Centre Comparing Erector Spinae Plane Blocks, Serratus Anterior Plane Blocks and Epidurals |
Actual Study Start Date : | November 11, 2020 |
Actual Primary Completion Date : | March 4, 2021 |
Actual Study Completion Date : | March 30, 2021 |

Group/Cohort | Intervention/treatment |
---|---|
Thoracic epidural for rib fracture management
Patients aged > 18 years of age presenting with traumatic rib fractures in a major trauma centre over the past 5 years that meet the criteria for the Imperial College Healthcare National Health Service (NHS) Trust 'Invasive rib fracture management pathway'
|
Procedure: Regional Anaesthesia
Thoracic epidural/Erector Spinae block/Serratus Anterior block |
Erector Spinae block for rib fracture management
Patients aged > 18 years of age presenting with traumatic rib fractures in a major trauma centre over the past 5 years that meet the criteria for the Imperial College Healthcare NHS Trust 'Invasive rib fracture management pathway'
|
Procedure: Regional Anaesthesia
Thoracic epidural/Erector Spinae block/Serratus Anterior block |
Serratus Anterior block for rib fracture management
Patients aged > 18 years of age presenting with traumatic rib fractures in a major trauma centre over the past 5 years that meet the criteria for the Imperial College Healthcare NHS Trust 'Invasive rib fracture management pathway'
|
Procedure: Regional Anaesthesia
Thoracic epidural/Erector Spinae block/Serratus Anterior block |
- The proportion of patients with a reduction in pain [ Time Frame: 72 hours ]The investigators will review pain scores as recorded by clinical staff over 72 hours to assess pain relief efficacy, A verbal rating scale classifying pain as mild, moderate or severe is used at Imperial Data from the acute pain round records will also provide details regarding breathing comfort levels of the patient, coughing ability and deep inspiratory effort. These are recorded as yes/no answers and the team will assess the proportion of patients showing a reduction in pain scores.
- Opioid Type [ Time Frame: 72 hours ]Data regarding type of opiate use
- Opioid mode of delivery [ Time Frame: 72 hours ]Mode of delivery of opioids
- Opioid use [ Time Frame: 72 hours ]Dosage requirement every 24 hours for a total of 72 hours
- Opioid complication(s) [ Time Frame: 72 hours ]Complications associated with opiates such as constipation, delirium and respiratory depression.
- Nausea and vomiting [ Time Frame: Time zero ]The incidence of nausea and vomiting pre-chest wall block
- NUmber of nausea and vomiting episodes [ Time Frame: 72 hours post block ]The incidence of nausea in the 72 hours post block will be recorded with the number of episodes
- Anti-emetic(s) used [ Time Frame: 72 hours post block ]The incidence of nausea in the 72 hours post block will be recorded with the number of anti-emetic medications required to treat.
- Lower respiratory tract infections [ Time Frame: Length of stay up 8 weeks ]Lower Respiratory Tract Infection (LRTI): for this study is defined as patients showing clinical features of chest infection including pyrexia (temperature >37.5°C), an increase in oxygen requirements from baseline, radiological evidence of chest infection or antimicrobial treatment of an LRTI started by the treating team.
- Respiratory complication(s) [ Time Frame: Length of stay up to 8 weeks ]Empyema/Parapneumonic effusions: defined as radiological evidence of fluid collections within the pleural space and therapeutic interventions required for treatment e.g. aspiration and drainage.
- Intensive care admission for respiratory complications [ Time Frame: Length of stay up to 8 weeks ]ICU admission for respiratory complications
- Intensive care admission [ Time Frame: Length of stay up to 8 weeks ]Number of patients requiring intubation and ventilation
- Intensive care mechanical ventilation [ Time Frame: Length of stay up to 8 weeks ]Number of days of mechanical ventilation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
- Patients aged > 18 years of age presenting with traumatic rib fractures in a major trauma centre over the past 5 years
- Meet the criteria for the Imperial College Healthcare NHS Trust 'Invasive rib fracture management pathway' (see Appendix A)
Inclusion Criteria:
- Patients aged > 18 years of age presenting with traumatic rib fractures in a major trauma centre over the past 5 years
- Meet the criteria for the Imperial College Healthcare NHS Trust 'Invasive rib fracture management pathway'
Exclusion Criteria:
- Under 18 years old
- Prisoners
- Pregnant
- Private patients
- Meet the criteria for the Imperial College Healthcare NHS Trust 'Non-invasive rib fracture management pathway'

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04863807
United Kingdom | |
Imperiial Collge Healthcare NHS Trust | |
London, United Kingdom, W2 1NY |
Principal Investigator: | Boyne Bellew | Imperial College Healthcare NHS Trust |
Responsible Party: | Imperial College Healthcare NHS Trust |
ClinicalTrials.gov Identifier: | NCT04863807 |
Other Study ID Numbers: |
19SM5668 276933 ( Other Identifier: HRA and Health and Care Research Wales (HCRW) ) |
First Posted: | April 28, 2021 Key Record Dates |
Last Update Posted: | April 28, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
epidural erector spinae block serratus anterior block |
Acute Pain Fractures, Bone Rib Fractures Wounds and Injuries Pain |
Neurologic Manifestations Thoracic Injuries Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |